410 related articles for article (PubMed ID: 12190204)
21. [Systemic lupus erythematosus induced by d-penicillamine in Wilson's disease: apropos of a case].
López-Guerra N; Alvarez Lario B; García-Moncó C; Peña Sagredo JL
Med Clin (Barc); 1987 Apr; 88(13):552-4. PubMed ID: 3586738
[No Abstract] [Full Text] [Related]
22. Penicillamine-induced Elastosis Perforans Serpiginosa in Wilson Disease: Is Useful Switching to Zinc?
Ranucci G; Di Dato F; Leone F; Vajro P; Spagnuolo MI; Iorio R
J Pediatr Gastroenterol Nutr; 2017 Mar; 64(3):e72-e73. PubMed ID: 25341025
[No Abstract] [Full Text] [Related]
23. D-penicillamine elastosis perforans serpiginosa: description of two cases and review of the literature.
Atzori L; Pinna AL; Pau M; Aste N
Dermatol Online J; 2011 Apr; 17(4):3. PubMed ID: 21549078
[TBL] [Abstract][Full Text] [Related]
24. Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease.
Berger B; Mader I; Damjanovic K; Niesen WD; Stich O
Clin Neurol Neurosurg; 2014 Dec; 127():122-4. PubMed ID: 25459257
[No Abstract] [Full Text] [Related]
25. [Regression of a Kayser-Fleischer ring in a case of Wilson's disease during penicillamine therapy (author's transl)].
Hiti H; Harpf H; Wutz W; Schmut O
Klin Monbl Augenheilkd; 1980 Feb; 176(2):235-8. PubMed ID: 7420971
[TBL] [Abstract][Full Text] [Related]
26. [Nephrotic syndrome secondary to d-penicillamine in a patient with Wilson's disease].
Castellví Suaña JM; Xiol Quingles X; Castellote Alonso J; Guardiola Capón J
Rev Clin Esp; 1993 Oct; 193(6):343-4. PubMed ID: 8259463
[No Abstract] [Full Text] [Related]
27. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
28. [Cutis hyperelastica following prolonged administration of penicillamine in a patient with Wilson's disease].
Charlebois G; Cadotte M; Barbeau A
Union Med Can; 1972 May; 101(5):893-5. PubMed ID: 4666894
[No Abstract] [Full Text] [Related]
29. Ophthalmoscopic changes in a patient with Wilson's disease during long-term penicillamine therapy.
Dingle J; Havener WH
Ann Ophthalmol; 1978 Sep; 10(9):1227-30. PubMed ID: 736410
[TBL] [Abstract][Full Text] [Related]
30. [Penicillamine-induced elastosis perforans serpiginosa].
Wilhelm KP; Wolff HH
Hautarzt; 1994 Jan; 45(1):45-7. PubMed ID: 8150618
[TBL] [Abstract][Full Text] [Related]
31. Penicillamine hypersensitivity: successful desensitization of a patient with severe hepatic Wilson's disease.
Chan CY; Baker AL
Am J Gastroenterol; 1994 Mar; 89(3):442-3. PubMed ID: 8122662
[TBL] [Abstract][Full Text] [Related]
32. Chronic internuclear ophthalmoplegia. A manifestation of D-penicillamine cerebral vasculitis.
Pless M; Sandson T
J Neuroophthalmol; 1997 Mar; 17(1):44-6. PubMed ID: 9093961
[No Abstract] [Full Text] [Related]
33. Penicillamine-induced arthropathy in Wilson's disease.
Walshe JM; Golding DN
Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):4-6. PubMed ID: 122670
[No Abstract] [Full Text] [Related]
34. D-penicillamine-induced elastosis perforans serpiginosa in a child with juvenile rheumatoid arthritis. Report of a case and review of the literature.
Sahn EE; Maize JC; Garen PD; Mullins SC; Silver RM
J Am Acad Dermatol; 1989 May; 20(5 Pt 2):979-88. PubMed ID: 2523911
[TBL] [Abstract][Full Text] [Related]
35. [Contribution to the clarification of the pathogenesis of osteopathies in Wilson's disease. (Hepatolenticular degeneration)].
Vokrouhlická-RösslerovI ; Vodicková L; Neruda O
Vnitr Lek; 1967 Oct; 13(10):1018-22. PubMed ID: 5630545
[No Abstract] [Full Text] [Related]
36. [2 cases of verruciform perforating elastoma after prolonged administration of D-penicillamine in Wilson's disease].
Sfar Z; Lakhoua H; Hafsia M; Amor RB; Mahfoudh H; Hamza B; Abdallah CB
Tunis Med; 1977; 55(3):167-8. PubMed ID: 919044
[No Abstract] [Full Text] [Related]
37. [Long-term D-penicillamine therapy of Wilson's disease in childhood. Changes in blood coagulation and effects on the haematopoetic system].
Hayek HW; Schnack H; Widhalm S
Wien Klin Wochenschr; 1973 Feb; 85(8):122-5. PubMed ID: 4632215
[No Abstract] [Full Text] [Related]
38. [Wilson's disease and pregnancy].
Toulouse R; Poirier PY; de Villartay A; Kerisit J
J Gynecol Obstet Biol Reprod (Paris); 1974; 3(7):1057-62. PubMed ID: 4470769
[No Abstract] [Full Text] [Related]
39. [D-penicillamine-induced IgA deficiency in the therapy of Wilson's disease].
Ibel H; Feist D; Endres W; Belohradsky BH
Klin Padiatr; 1990; 202(6):427-9. PubMed ID: 2266710
[TBL] [Abstract][Full Text] [Related]
40. Penicillamine associated pulmonary hemorrhage.
Louie S; Gamble CN; Cross CE
J Rheumatol; 1986 Oct; 13(5):963-6. PubMed ID: 3820209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
